---
title: "Erasca appoints Charles Fuchs as president of R&D"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295404808.md"
description: "Erasca has appointed Charles S. Fuchs as its new president of research and development, effective immediately. Fuchs brings extensive experience, having most recently served as chief medical officer at Tubulis, where he led clinical strategy and pipeline development. His previous roles include senior oncology drug development positions at Genentech and Roche, as well as leadership posts at Yale Cancer Center and Dana-Farber."
datetime: "2026-08-10T12:07:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295404808.md)
  - [en](https://longbridge.com/en/news/295404808.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295404808.md)
---

# Erasca appoints Charles Fuchs as president of R&D

-   Erasca named Charles S. Fuchs president of research and development, effective immediately. \* Fuchs most recently served as chief medical officer at Tubulis, where he led clinical strategy and pipeline development. \* He previously held senior oncology drug development roles at Genentech and Roche, following earlier leadership posts at Yale Cancer Center and Dana-Farber. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Erasca Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608100800PRIMZONEFULLFEED9806331) on August 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [ERAS.US](https://longbridge.com/en/quote/ERAS.US.md)
- [RHHBY.US](https://longbridge.com/en/quote/RHHBY.US.md)
- [RHHVF.US](https://longbridge.com/en/quote/RHHVF.US.md)

## Related News & Research

- [Erasca rilis presentasi korporat soal pengembangan terapi kanker berbasis jalur RAS/MAPK](https://longbridge.com/en/news/295578619.md)
- [Erasca files Form 3 for President, R&D Charles S. Fuchs](https://longbridge.com/en/news/295705135.md)
- [10:30 ETCancer Diagnostics Market worth $44.92 billion by 2031 - Exclusive Report by MarketsandMarkets™](https://longbridge.com/en/news/296121121.md)
- [Granite-Integral co-leads $34 million Series D financing in Craif](https://longbridge.com/en/news/296226716.md)
- [Cancer diagnostics firm Precipio's Q2 revenue rises, adjusted EBITDA turns positive](https://longbridge.com/en/news/295970219.md)